Yasuhiro Nishida Selected Research

Abducens Nerve Diseases (Sixth Nerve Palsy)

2/2015	Long-Term Outcomes of Three Cases That Underwent a Muscle Transposition Procedure Without Tenotomy Caused by Abducens Palsy.
10/2013	Surgical results of a muscle transposition procedure for abducens palsy without tenotomy and muscle splitting.
3/2005	A simple muscle transposition procedure for abducens palsy without tenotomy or splitting muscles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Nishida Research Topics

Disease

6	Inflammation (Inflammations) 12/2021 - 08/2003
6	Graves Ophthalmopathy 01/2016 - 07/2002
5	Hypertension (High Blood Pressure) 01/2017 - 07/2009
4	Insulin Resistance 12/2021 - 08/2013
3	Hemorrhage 01/2018 - 02/2015
3	Exophthalmos (Proptosis) 11/2015 - 07/2002
3	Abducens Nerve Diseases (Sixth Nerve Palsy) 02/2015 - 03/2005
3	Color Vision Defects (Color Blindness) 01/2004 - 06/2002
2	Glucose Intolerance 12/2021 - 01/2020
2	Hypoxia (Hypoxemia) 12/2021 - 01/2018
2	Obesity 12/2021 - 08/2013
2	Hypotension (Low Blood Pressure) 11/2016 - 04/2011
2	Heart Failure 08/2010 - 07/2009
1	Hypertrophy 01/2020
1	Optic Neuritis (Retrobulbar Neuritis) 01/2017
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 06/2016
1	Ganglion Cysts (Ganglion) 06/2016
1	Ischemia 04/2016
1	Brain Ischemia (Cerebral Ischemia) 04/2016
1	Lung Injury 01/2016
1	Shock 01/2016
1	Neoplasms (Cancer) 01/2016
1	Thrombocytopenia (Thrombopenia) 02/2015
1	Esotropia (Esophoria) 10/2013
1	Type 2 Diabetes Mellitus (MODY) 08/2013
1	Essential Hypertension 04/2013
1	Optic Nerve Diseases (Optic Neuropathy) 04/2006
1	Ophthalmoplegia (External Ophthalmoplegia) 04/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2003
1	Atherosclerosis 08/2003
1	Neointima 08/2003
1	Cataract (Cataracts) 11/2002

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 04/2016
4	Troleandomycin (TAO)FDA Link 11/2015 - 07/2002
4	SaltsIBA 04/2013 - 07/2009
3	AntioxidantsIBA 12/2021 - 08/2013
3	astaxanthine (astaxanthin)IBA 12/2021 - 08/2013
3	Retinaldehyde (Retinal)IBA 01/2017 - 01/2016
3	CytokinesIBA 01/2017 - 08/2003
3	Adenosine (Adenocard)FDA LinkGeneric 04/2016 - 02/2015
3	Methylprednisolone FDA LinkGeneric 01/2016 - 03/2015
2	Insulin (Novolin)FDA Link 01/2017 - 08/2013
2	Oxygen (Dioxygen)IBA 11/2016 - 04/2016
2	Diphosphates (Pyrophosphates)IBA 01/2016 - 02/2015
2	Fibrinogen (Factor I)FDA Link 01/2016 - 02/2015
2	Phosphates (Orthophosphate)IBA 01/2016 - 02/2015
2	Peptides (Polypeptides)IBA 01/2016 - 02/2015
2	Liposomes (Liposome)IBA 01/2016 - 02/2015
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2013 - 07/2009
2	Retinal Pigments (Pigments, Visual)IBA 01/2004 - 03/2003
1	Dihydrotachysterol (AT 10)IBA 12/2021
1	Phosphotransferases (Kinase)IBA 01/2020
1	LipidsIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	Erythropoietin FDA Link 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	IncretinsIBA 01/2017
1	Neuroprotective AgentsIBA 04/2016
1	Adenosine DeaminaseIBA 04/2016
1	Adenosine A2B ReceptorIBA 01/2016
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Purinergic P1 Receptor AntagonistsIBA 01/2016
1	1-propyl-8-(4-sulfophenyl)xanthineIBA 01/2016
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2016
1	ZM 241385 (ZM241385)IBA 01/2016
1	Hemostatics (Antihemorrhagics)IBA 02/2015
1	Adenosine Diphosphate (ADP)IBA 02/2015
1	PalmitatesIBA 08/2013
1	Carotenoids (Carotene)IBA 08/2013
1	Nonesterified Fatty Acids (NEFA)IBA 08/2013
1	BuffersIBA 03/2013
1	Dantrolene (Dantrium)FDA LinkGeneric 04/2011
1	Losartan (Cozaar)FDA LinkGeneric 07/2009
1	Angiotensin IIIBA 07/2009
1	InterleukinsIBA 08/2003
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 08/2003
1	Intergenic DNA (Junk DNA)IBA 03/2003
1	Proteins (Proteins, Gene)FDA Link 11/2002
1	Capsules (Microcapsules)IBA 11/2002
1	middle-wavelength opsinIBA 06/2002

Therapy/Procedure

5	Aftercare (After-Treatment) 01/2017 - 03/2015
3	Therapeutics 01/2016 - 03/2015
3	Tenotomy 02/2015 - 03/2005
1	Resuscitation 01/2018
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2018
1	Lasers (Laser) 01/2016
1	Sutures (Suture) 10/2013
1	Decompression 04/2006